ConductScience.org, home

Paper6561069

Enhanced K-cell activity in the peripheral blood of patients with malignant disease.

Bakács T and 5 others. Cancer Immunol Immunother, 1984. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Enhanced K-cell activity in the peripheral blood of patients with malignant disease. Papers, record 6561069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6561069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced K-cell activity in the peripheral blood of patients with malignant disease.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2024-04-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bakács TT
2Czanik PP
3Kimber II
4Ringwald GG
5Moore MM
6Abrahám EE

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
NeoplasmsMajor topic
Antibody-Dependent Cell Cytotoxicity
Female
Humans
Male
Middle Aged
Sex Factors

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16166701Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.J Exp Med1981https://conductscience.org/library/papers/6166701PubMed
2479605Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals.J Immunol1979https://conductscience.org/library/papers/479605PubMed
34159466The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes.Vox Sang1965https://conductscience.org/library/papers/4159466PubMed
4832266Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.Cancer Res1977https://conductscience.org/library/papers/832266PubMed
57138766Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.Br J Cancer1982https://conductscience.org/library/papers/7138766PubMed
66260947Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations.J Clin Lab Immunol1981https://conductscience.org/library/papers/6260947PubMed
74179068Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.Scand J Clin Lab Invest Suppl1968https://conductscience.org/library/papers/4179068PubMed
86171028Selective enhancement of human mononuclear leucocyte cytotoxic function by interferon.Scand J Immunol1981https://conductscience.org/library/papers/6171028PubMed
9306592Lymphocyte mediated natural cytotoxicity in neoplasia.Oncology1978https://conductscience.org/library/papers/306592PubMed
106219125Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.J Clin Immunol1983https://conductscience.org/library/papers/6219125PubMed
117240748In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.J Immunol1981https://conductscience.org/library/papers/7240748PubMed
127216547In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background.Int J Cancer1980https://conductscience.org/library/papers/7216547PubMed
136185128Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.Br J Cancer1982https://conductscience.org/library/papers/6185128PubMed
14748180Is antibody-dependent cellular cytotoxicity an important mechanism of resistance to tumors in vivo?Immunochemistry1978https://conductscience.org/library/papers/748180PubMed
156765619Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cells.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6765619PubMed
167287227Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumor cells.Int J Cancer1981https://conductscience.org/library/papers/7287227PubMed
176965233Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remission.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6965233PubMed
18155876Cytotoxic effects of activated human monocytes and lymphocytes to anti-D-treated human erythrocytes in vitro.Scand J Immunol1979https://conductscience.org/library/papers/155876PubMed
19408421Cytotoxic activity of human lymphocytes: quanitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics.J Immunol1977https://conductscience.org/library/papers/408421PubMed
20956652HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans.J Immunol1976https://conductscience.org/library/papers/956652PubMed

See all 22 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn Papers
2936448Immune surveillance and natural resistance: an evaluation.Cancer Immunol Immunother1986https://conductscience.org/library/papers/2936448

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6561069

GET https://conductscience.org/api/papers/v1/6561069/references?page=2